Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Amgen share Repurchases — Remaining Board Authorization Available ($M) ($M)
Form 10-Q / 10-K Stockholders' Equity Note (XBRL)
Latest, Q2 2026
6,800
Period ended Jun 30, 2026
Change on a year earlier
0.0%
6,800 in Q2 2025
History
46 quarters
Since Q1 2015
Sources
40
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share Repurchases — Remaining Board Authorization Available ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 6,800 | 0.0% | Form 10-Q (filed 2026-08-05) ↗ |
| Q1 2026 | Mar 31, 2026 | 6,800 | 0.0% | Form 10-Q (filed 2026-05-01) ↗ |
| Q4 2025 | Dec 31, 2025 | 6,800 | 0.0% | Form 10-K (filed 2026-02-13) ↗ |
| Q3 2025 | Sep 30, 2025 | 6,800 | -2.9% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 6,800 | -2.9% | Form 10-Q (filed 2025-08-06) ↗ |
| Q1 2025 | Mar 31, 2025 | 6,800 | -2.9% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 6,800 | -2.9% | Form 10-K (filed 2025-02-14) ↗ |
| Q3 2024 | Sep 30, 2024 | 7,000 | 0.0% | Form 10-Q (filed 2024-10-31) ↗ |
| Q2 2024 | Jun 30, 2024 | 7,000 | 0.0% | Form 10-Q (filed 2024-08-07) ↗ |
| Q1 2024 | Mar 31, 2024 | 7,000 | 0.0% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 7,000 | 0.0% | Form 10-K (filed 2024-02-14) ↗ |
| Q3 2023 | Sep 30, 2023 | 7,000 | +52.2% | Form 10-Q (filed 2023-10-31) ↗ |
| Q2 2023 | Jun 30, 2023 | 7,000 | +52.2% | Form 10-Q (filed 2023-08-04) ↗ |
| Q1 2023 | Mar 31, 2023 | 7,000 | +52.2% | Form 10-Q (filed 2023-04-28) ↗ |
| Q4 2022 | Dec 31, 2022 | 7,000 | -35.8% | Form 10-K (filed 2023-02-09) ↗ |
| Q3 2022 | Sep 30, 2022 | 4,600 | +58.6% | Form 10-Q (filed 2022-11-04) ↗ |
| Q2 2022 | Jun 30, 2022 | 4,600 | +17.9% | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 4,600 | -16.4% | Form 10-Q (filed 2022-04-28) ↗ |
| Q4 2021 | Dec 31, 2021 | 10,900 | +263.3% | Form 10-K (filed 2022-02-16) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,900 | -31.0% | Form 10-Q (filed 2021-11-03) ↗ |
| Q2 2021 | Jun 30, 2021 | 3,900 | -20.4% | Form 10-Q (filed 2021-08-04) ↗ |
| Q1 2021 | Mar 31, 2021 | 5,500 | 0.0% | Form 10-Q (filed 2021-04-28) ↗ |
| Q4 2020 | Dec 31, 2020 | 3,000 | -53.8% | Form 10-K (filed 2021-02-09) ↗ |
| Q3 2020 | Sep 30, 2020 | 4,200 | +16.7% | Form 10-Q (filed 2020-10-29) ↗ |
| Q2 2020 | Jun 30, 2020 | 4,900 | +4.3% | Form 10-Q (filed 2020-07-29) ↗ |
| Q1 2020 | Mar 31, 2020 | 5,500 | +161.9% | Form 10-Q (filed 2020-05-01) ↗ |
| Q4 2019 | Dec 31, 2019 | 6,500 | +27.5% | Form 10-K (filed 2020-02-12) ↗ |
| Q3 2019 | Sep 30, 2019 | 3,600 | -2.7% | Form 10-Q (filed 2019-10-30) ↗ |
| Q2 2019 | Jun 30, 2019 | 4,700 | -13.0% | Form 10-Q (filed 2019-07-31) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,100 | -41.7% | Form 10-Q (filed 2019-05-01) ↗ |
| Q4 2018 | Dec 31, 2018 | 5,100 | +15.9% | Form 10-K (filed 2019-02-13) ↗ |
| Q3 2018 | Sep 30, 2018 | 3,700 | +117.6% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jun 30, 2018 | 5,400 | +116.0% | Form 10-Q (filed 2018-07-27) ↗ |
| Q1 2018 | Mar 31, 2018 | 3,600 | +2.9% | Form 10-Q (filed 2018-04-25) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,400 | +7.3% | Form 10-K (filed 2018-02-13) ↗ |
| Q3 2017 | Sep 30, 2017 | 1,700 | -41.4% | 10-Q FY2017 (XBRL) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,500 | -30.6% | 10-Q FY2017 (XBRL) ↗ |
| Q1 2017 | Mar 31, 2017 | 3,500 | -16.7% | 10-Q FY2017 (XBRL) ↗ |
| Q4 2016 | Dec 31, 2016 | 4,100 | -18.0% | Form 10-K (filed 2017-02-14) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,900 | +31.8% | 10-Q FY2016 (XBRL) ↗ |
| Q2 2016 | Jun 30, 2016 | 3,600 | +24.1% | 10-Q FY2016 (XBRL) ↗ |
| Q1 2016 | Mar 31, 2016 | 4,200 | +23.5% | 10-Q FY2016 (XBRL) ↗ |
| Q4 2015 | Dec 31, 2015 | 5,000 | – | Form 10-K (filed 2016-02-16) ↗ |
| Q3 2015 | Sep 30, 2015 | 2,200 | – | 10-Q FY2015 (XBRL) ↗ |
| Q2 2015 | Jun 30, 2015 | 2,900 | – | 10-Q FY2015 (XBRL) ↗ |
| Q1 2015 | Mar 31, 2015 | 3,400 | – | 10-Q FY2015 (XBRL) ↗ |
Cite this data
StockData. (2026). Amgen Share Repurchases — Remaining Board Authorization Available ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/buyback_auth_rem
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.